Golgi Protein for HCC Diagnosis

Ain Shams University90 enrolled

Overview

This case-control study was conducted on 90 patients who were equally divided into two groups. Group 1 included 45 patients with HCV-related chronic liver disease without clinical or radiological evidence of HCC (control group), and Group 2 included 45 patients diagnosed to have HCC by Triphasic abdominal CT (patient group). Serum AFP and GP73 were measured using ELISA technique

Study Type

OBSERVATIONAL

Enrollment

Conditions

Screening for Hepatocellular Carcinoma

Interventions

Serum Golgi Protein 73DIAGNOSTIC_TEST

Serum test

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients were older than 18 years. Exclusion Criteria: * patients with hepatic focal lesions not due to HCC such as Hemangioma, Hepatic cyst, and liver metastases; patients infected with HIV; patients with any autoimmune disease; or patients with metastatic disease.

Outcomes

Primary Outcomes

Golgi protein correlated with presence of HCC

Time frame: within one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.